中麻黄悬浮培养体系的建立

本文用中麻黄无菌苗为外植体,其切段培养在附加２ｍｇ／Ｌ２,４－Ｄ和０．５ｍｇ／Ｌ　６　ＢＡ的ＭＳ培养基上,全部脱分化形成白色疏松愈伤组织。愈伤组织继代培养于ＭＳ＋０．５ｍｇ／Ｌ２,４－Ｄ＋０．２ｍｇ／Ｌ６ＢＡ＋０．２ｍｇ／Ｌ　ＮＡＡ＋４％蔗糖的培养某上。以继代培养愈伤组织为材料进行悬浮培养,培养基为附加０．２ｍｇ／Ｌ２,４－Ｄ＋０．１ｍｇ／Ｌ６ＢＡ＋０．１ｍｇ／ＬＮＡＡ＋２％蔗糖的ＭＳ液体培养基,得到分散性好,细胞形状接近圆形,细胞大小均一,细胞团多由２－３０个细胞组成的悬浮培养体系。第三代悬浮培养细胞增长率为０．３５ｇ·ｆｗ／２０ｍｌ·ｄ,细胞有丝分裂指数为１１．２％。条件培养和高密度接种可缩短延迟期,条件培养不能提高分裂指数,１ｇ／１０ｍｌ接种密度可使分裂指数提高至２１．２％。     

香椿离体快繁技术研究

６～７月取香棒当年生半木质化、具腋芽的茎段为外植体,诱导腋芽萌发,进行繁殖培养。通过大量试验,筛选出各阶段适宜的培养基组成。萌芽诱导阶段培养在ＭＳ＋６－ＢＡ０．２ｍｇ／Ｌ中,腋芽萌发早,生长快;在继代和增殖培养中以ＭＳ＋６－ＢＡ０．２ｍｇ／Ｌ效果较好,ＭＳ＋ＺＴ０．２ｍｇ／Ｌ＋ＧＡ３２．０ｍｇ／Ｌ次之。培养３０天繁殖倍数３．１～４．０,在仅含ＭＳ有机元素。铁盐减半、蔗糖１５ｇ／Ｌ的固体培养基中,附     

大叶紫花苜蓿愈伤组织原生质体再生植株

大叶紫花苜蓿下胚轴诱导的愈伤组织在继代培养基上生长快速,易于分散。继代第１２ｄ的愈伤组织原生质体的得率为６．５×１０７／ｇ鲜重。原生质体培养基为ＳＨ基本培养基,含有１．０ｍｇ／Ｌ２,４－０、０．５ｍｇ／ＬＢＡ、２．０ｇ／ＬＣＨ、２％蔗糖、６％葡萄糖、５ｍｍｏｌ／ＬＭＥＳ,培养密度为１．０×１０５／ｍＬ。培养至第１２ｄ时的原生质体再生细胞植板率为３．７％。由原生质体形成的小愈伤组织在含２．０ｍｇ／Ｌ２,４－Ｄ的ＭＳ固体培养基上大量增殖。增殖的愈伤组织转移至２．０ｍｇ／Ｌ２－ｉｐ＋０．１ｍｇ／ＬＮＡＡ的Ｂ５培养基上,形成体细胞胚并发育成完整植株。     

秦艽体细胞愈伤组织诱导及继代研究

本文报道了秦艽取叶、幼苗为外植体诱导愈伤组织试验。结果表明,取幼苗６７－Ⅴ培养基,２４－Ｄ２５ｍｇ／Ｌ,ＮＡＡ０５ｍｇ／Ｌ,诱导频率最优,可高达１００％。继代培养,以６７％培养基,ＮＡＡ０５ｍｇ／Ｌ,２４－Ｄ（１－１５）ｍｇ／Ｌ最优     

青蒿毛状根合成青蒿素的培养条件研究

对影响青蒿（ＡｒｔｅｍｉｓｉａａｎｎｕａＬ．）毛状根生长及青蒿素合成的培养条件进行了研究,确定最适的培养条件为：初始ｐＨ５．８～６．０,摇瓶转速１３０～１５０ｒ／ｍｉｎ,摇瓶装液量体积分数为２５％,光照周期为１６ｈ／ｄ,温度为３０℃。在此条件下,经过２５ｄ培养获得青蒿素产量为２２３．３ｍｇ／Ｌ。     

高寒藏药—抱茎獐牙菜组织培养研究及其愈伤组织有效成分的测定

从抱茎獐牙菜的胚轴、幼叶及未成熟种子诱导出愈伤组织并再生植株,试验选用ＭＳ、Ｂ５和Ｎ６三种培养基,其中以附加２．４－Ｄ３．０ｍｇ／Ｌ＋６－ＢＡ０．５ｍｇ／Ｌ的ＭＳ培养基诱导率最高;以附加６－ＢＡ０．５ｍｇ／Ｌ＋ＮＡＡ０．２ｍｇ／Ｌ的ＭＳ培养基分化苗频率最高;以附加２．４－Ｄ２．０ｍｇ／Ｌ＋６－ＢＡ０．５ｍｇ／Ｌ的ＭＳ培养基愈伤组织的生长最好。结果表明,外植体,培养基,激素等对愈伤组织诱导、继代和分化均有明显影响。采用高压液相色谱法（ＨＰＬＣ）测定抱茎獐牙菜愈伤组织中齐墩果酸含量的结果表明,愈伤组织中齐果墩酸含量因培养基、继代培养时间的不同而有所差异     

枸杞髓组织离体培养及高频率植株再生的研究

枸杞髓组织在４种ＭＳ培养基上都能诱导出愈伤组织,诱导率５３．７％～１００％。在培养基ＭＳ＋６－ＢＡ０．１ｍｇ／Ｌ＋ＮＡＡ０．５ｍｇ／Ｌ获得的愈伤组织,呈颗粒状,分散性能好,胚性细胞多．将其转移到ＭＳ＋６－ＢＡ０．５ｍｍ／Ｌ＋ＮＡＡ０．０１ｍｇ／Ｌ的分化培养基上获得大量绿色小芽,小芽在ＭＳ＋６－ＢＡ０．２ｍｇ／Ｌ的培养基上得到快速繁殖,繁殖系数５０～１５０株／芽·月。丛生芽在ＭＳ＋ＮＡＡ０．２ｔｍｇ／Ｌ的培养基上形成完整植株     

杜仲愈伤组织超低温保存的研究

采用单因子比较、正交设计和均匀设计法,分别考察影响杜仲愈伤组织诱导、生长及其超低温保存的因素。试验表明：Ｂ５＋ＮＡＡ０．５ｍｇ／Ｌ＋６—ＢＡ１ｍｇ／Ｌ有利于意伤组织诱导。ＭＳ＋２．４—Ｄ３ｍｇ／Ｌ＋６—ＢＡ０．５ｍｇ／Ｌ则有利于愈伤组织快速生长。超低温保存的最佳材料是２周龄的愈伤组织。愈伤组织超低温保存的较好冷冻保护剂是１２．５％Ｇｌｙ＋７．５％ＰＥＧ＋２．５ｇ／ＬＬＨ。     

香椿的组织培养和玻璃苗的防止

１植物名称香椿（Ｔｏｏｎａｓｉｎｅｎｓｉｓ）。２材料类别（１）种子发芽３～５ｄ后的下胚轴及带少许下胚轴的子叶;（２）当年生半木质化的腋芽茎段。３培养条件芽诱导及增殖培养,以ＭＳ为基本培养基,蔗糖３０ｇ·Ｌ~（－１）,琼脂０．５％,附加激素（单位ｍｇ·Ｌ~（－１））：（１）６－ＢＡ０．２;（２）６－ＢＡ０．２、ＧＡ_３２．０;（３）ＩＡＡ０．１、６ＢＡ０．２;（４）ＺＴ０．２、ＧＡ_３２．０。诱导生根培养基为１／ＺＭＳ或仅含ＭＳ有机质（铁盐减半）,附加１．０ｍｇ·Ｌ~（－１）ＩＢＡ、１５ｇ·Ｌ~（－１）…     

墨兰的无菌播种和植株再生

墨兰的无菌播种结果发现,在不添加细胞分裂素的培养基上,种子可以发芽,但只有原球茎和根状茎产生,不可能进一步分化成苗,只有在含有不同激素成分ＭＳ或ＫｎｕｄｓｏｎＣ培养基上,才有可能诱导芽的分化,其中以附加６－ＢＡ０．５－１．０ｍｇ／Ｌ＿ＮＡＡ０．１ｍｇ／Ｌ诱导效果最佳,在附加６－ＢＡ２．０ｍｇ／Ｌ＋ＮＡＡ０．４ｍｇ／Ｌ的ＭＳ培养基中,能加速芽的增殖,根状茎转入含有相同激素成分的液体增殖培养基中振荡培     

Evidence of artemisinin production from IPP stemming from both the mevalonate and the nonmevalonate pathways

The potent antimalarial sesquiterpene lactone, artemisinin, is produced in low quantities by the plant Artemisia annua L. The source and regulation of the isopentenyl diphosphate (IPP) used in the biosynthesis of artemisinin has not been completely characterized. Terpenoid biosynthesis occurs in plants via two IPP-generating pathways: the mevalonate pathway in the cytosol, and the non-mevalonate pathway in plastids. Using inhibitors specific to each pathway, it is possible to resolve which supplies the IPP precursor to the end product. Here, we show the effects of inhibition on the two pathways leading to IPP for artemisinin production in plants. We grew young (7–14 days post cotyledon) plants in liquid culture, and added mevinolin to the medium to inhibit the mevalonate pathway, or fosmidomycin to inhibit the non-mevalonate pathway. Artemisinin levels were measured after 7–14 days incubation, and production was significantly reduced by each inhibitor compared to controls, thus, it appears that IPP from both pathways is used in artemisinin production. Also when grown in miconazole, an inhibitor of sterol biosynthesis, there was a significant increase in artemisinin compared to controls suggesting that carbon was shifted from sterols into sesquiterpenes. Collectively these results indicate that artemisinin is probably biosynthesized from IPP pools from both the plastid and the cytosol, and that carbon from competing pathways can be channeled toward sesquiterpenes. This information will help advance our understanding of the regulation of in planta production of artemisinin.     

Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.

Some bisphosphonates used for the treatment of bone disorders are also potent inhibitors of squalene synthase, a critical enzyme for sterol biosynthesis. Among seven drugs tested, YM 175 (cycloheptylaminomethylene-1,1-bisphosphonic acid) was the most potent inhibitor of rat liver microsomal squalene synthase (Ki = 57 nM) and sterol biosynthesis from [14C]mevalonate in rat liver homogenate (IC50 = 17 nM). EB 1053 (3-(1-pyrolidino)-1-hydroxypropylidene-1,1-bisphosphonic acid) and PHPBP (3-(1-piperidino)-1-hydroxypropylidene-1,1-bisphosphonic acid) were less potent inhibitors in both these assays. Pamidronate and alendronate were poor inhibitors of squalene synthase (IC50 > 10 microM) but were potent inhibitors of sterol biosynthesis from mevalonate (IC50 = 420 and 168 nM, respectively), suggesting that the latter two agents may have inhibited other enzymes involved in the synthesis of farnesyl pyrophosphate from mevalonate. Etidronate and clodronate were inactive in both these assays. YM 175 also inhibited sterol biosynthesis in mouse macrophage J774 cells (IC50 = 64 microM) and in rats, when administered acutely, it inhibited cholesterol biosynthesis in the liver (ED50 = 30 mg/kg, s.c.). Structural modifications on YM 175 to enhance cell permeability may result in a new class of cholesterol-lowering agents.     

Sterol-independent regulation of 3-hydroxy-3-methylglutaryl-CoA reductase by mevalonate in Chinese hamster ovary cells. Magnitude and specificity

In this paper, we assess the relative degree of regulation of the rate-limiting enzyme of isoprenoid biosynthesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, by sterol and nonsterol products of mevalonate by utilizing cultured Chinese hamster ovary cells blocked in sterol synthesis. We also examine the two other enzymes of mevalonate biosynthesis, acetoacetyl-CoA thiolase and HMG-CoA synthase, for regulation by mevalonate supplements. These studies indicate that in proliferating fibroblasts, treatment with mevalonic acid can produce a suppression of HMG-CoA reductase activity similar to magnitude to that caused by oxygenated sterols. In contrast, HMG-CoA synthase and acetoacetyl-CoA thiolase are only weakly regulated by mevalonate when compared with 25-hydroxycholesterol. Furthermore, neither HMG-CoA synthase nor acetoacetyl-CoA thiolase exhibits the multivalent control response by sterol and mevalonate supplements in the absence of endogenous mevalonate synthesis which is characteristic of nonsterol regulation of HMG-CoA reductase. These observations suggest that nonsterol regulation of HMG-CoA reductase is specific to that enzyme in contrast to the pleiotropic regulation of enzymes of sterol biosynthesis observed with oxygenated sterols. In Chinese hamster ovary cells supplemented with mevalonate at concentrations that are inhibitory to reductase activity, at least 80% of the inhibition appears to be mediated by nonsterol products of mevalonate. In addition, feed-back regulation of HMG-CoA reductase by endogenously synthesized nonsterol isoprenoids in the absence of exogenous sterol or mevalonate supplements also produces a 70% inhibition of the enzyme activity.     

青蒿素生物合成分子调控研究进展

青蒿素是目前世界上最有效的疟疾治疗药物。通过对青蒿素的生物合成途径,青蒿素生物合成途径的关键酶,青蒿素生物合成的分子调控的介绍,综述了青蒿素生物合成分子调控的最新研究进展。     

Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase

To get some insight into the regulatory mechanisms controlling the sterol branch of the mevalonate pathway, tobacco (Nicotiana tabacum cv Bright Yellow-2) cell suspensions were treated with squalestatin-1 and terbinafine, two specific inhibitors of squalene synthase (SQS) and squalene epoxidase, respectively. These two enzymes catalyze the first two steps involved in sterol biosynthesis. In highly dividing cells, SQS was actively expressed concomitantly with 3-hydroxy-3-methylglutaryl coenzyme A reductase and both sterol methyltransferases. At nanomolar concentrations, squalestatin was found to inhibit efficiently sterol biosynthesis as attested by the rapid decrease in SQS activity and [(14)C]radioactivity from acetate incorporated into sterols. A parallel dose-dependent accumulation of farnesol, the dephosphorylated form of the SQS substrate, was observed without affecting farnesyl diphosphate synthase steady-state mRNA levels. Treatment of tobacco cells with terbinafine is also shown to inhibit sterol synthesis. In addition, this inhibitor induced an impressive accumulation of squalene and a dose-dependent stimulation of the triacylglycerol content and synthesis, suggesting the occurrence of regulatory relationships between sterol and triacylglycerol biosynthetic pathways. We demonstrate that squalene was stored in cytosolic lipid particles, but could be redirected toward sterol synthesis if required. Inhibition of either SQS or squalene epoxidase was found to trigger a severalfold increase in enzyme activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase, giving first evidence for a positive feedback regulation of this key enzyme in response to a selective depletion of endogenous sterols. At the same time, no compensatory responses mediated by SQS were observed, in sharp contrast to the situation in mammalian cells.     

Effect of sulphur nutrition on redistribution of sulphur in vegetative barley

Xenobiotics directed against sterol biosynthesis have proved to be useful tools in the determination of which sterol molecules are necessary for successful plant cell growth. However, the exact mode of action by which sterols are able to trigger cell growth remains to be elucidated. Previous studies using the triazole paclobutrazol, demonstrated that in Apium graveolens (cv. New Dwarf White) suspension cultures, sterol and phosphatidylcholine biosynthesis are co-ordinately regulated (C. E. Rolph and L. J. Goad 1991, Physiol. Plant. 83: 605–610). The studies presented herein, were designed to investigate the possible role of phosphatidylcholine in the stimulation of plant cell growth. Sterol biosynthesis, and hence cell growth, was inhibited by the use of the azole xenobiotic miconazole. Treatment of the cultures with miconazole lead to compositional changes in the free sterol content of the cells. For example, 30 μM miconazole treatment led to a reduction in the stigmasterol/sitosterol ratios from 1.53 to 1.24. In contrast, the phospholipid content of the cells remained relatively unchanged with phosphatidylcholine accounting for approximately 25% of the total phospholipids present in both control and miconazole-treated cells. The cytostatic effect of miconazole could be partially counteracted by supplementation of the growth medium with the phytosterol stigmasterol and/or the unsaturated fatty acids oleate and linoleate. The activity of CTP:cholinephosphate cytidylyltransferase (EC 2.7.7.15), a rate-limiting enzyme in phosphatidylcholine biosynthesis, was significantly reduced in cells whose growth had been arrested by miconazole treatment. In miconazole-treated cultures whose growth had been partially restored by supplementation with either specific sterols or unesterified fatty acids, the activity of this key enzyme was increased. In the case of stigmasterol, oleate and linoleate supplementation, the microsomal activity was found to be similar to that exhibited by control cultures. From these studies, it may be concluded that certain phytosterols and unsaturated fatty acids play key roles with respect to phosphatidylcholine biosynthesis and that phosphatidylcholine biosynthesis via the CDP-base pathway is an important pre- and/or co-requisite for successful culture growth.     

Both the mevalonate and the non-mevalonate pathways are involved in ginsenoside biosynthesis

Key Message

When one of them was inhibited, the two pathways could compensate with each other to guarantee normal growth. Moreover, the sterol biosynthesis inhibitor miconazole could enhance ginsenoside level.

Abstract

Ginsenosides, a kind of triterpenoid saponins derived from isopentenyl pyrophosphate (IPP), represent the main pharmacologically active constituents of ginseng. In plants, two pathways contribute to IPP biosynthesis, namely, the mevalonate pathway in cytosol and the non-mevalonate pathway in plastids. This motivates biologists to clarify the roles of the two pathways in biosynthesis of IPP-derived compounds. Here, we demonstrated that both pathways are involved in ginsenoside biosynthesis, based on the analysis of the effects from suppressing either or both of the pathways on ginsenoside accumulation in Panax ginseng hairy roots with mevinolin and fosmidomycin as specific inhibitors for the mevalonate and the non-mevalonate pathways, respectively. Furthermore, the sterol biosynthesis inhibitor miconazole could enhance ginsenoside levels in the hairy roots. These results shed some light on the way toward better understanding of ginsenoside biosynthesis.     

Amorpha-4,11-diene synthase: cloning and functional expression of a key enzyme in the biosynthetic pathway of the novel antimalarial drug artemisinin

The sesquiterpenoid artemisinin, isolated from the plant Artemisia annua L., and its semi-synthetic derivatives are a new and very effective group of antimalarial drugs. A branch point in the biosynthesis of this compound is the cyclisation of the ubiquitous precursor farnesyl diphosphate into the first specific precursor of artemisinin, namely amorpha-4,11-diene. Here we describe the isolation of a cDNA clone encoding amorpha-4,11-diene synthase. The deduced amino acid sequence exhibits the highest identity (50%) with a putative sesquiterpene cyclase of A. annua. When expressed in Escherichia coli, the recombinant enzyme catalyses the formation of amorpha-4,11-diene from farnesyl diphosphate. Introduction of the gene into tobacco (Nicotiana tabacum L.) resulted in the expression of an active enzyme and the accumulation of amorpha-4,11-diene ranging from 0.2 to 1.7 ng per g fresh weight. Received: 8 June 2000 / Accepted: 21 August 2000     

Methyl jasmonate and miconazole differently affect arteminisin production and gene expression in Artemisia annua suspension cultures

Artemisia annua L. is a herb traditionally used for treatment of fevers. The glandular trichomes of this plant accumulate, although at low levels, artemisinin, which is highly effective against malaria. Due to the great importance of this compound, many efforts have been made to improve knowledge on artemisinin production both in plants and in cell cultures. In this study, A. annua suspension cultures were established in order to investigate the effects of methyl jasmonate (MeJA) and miconazole on artemisinin biosynthesis. Twenty-two micro molar MeJA induced a three-fold increase of artemisinin production in around 30 min; while 200 μm miconazole induced a 2.5-fold increase of artemisinin production after 24 h, but had severe effects on cell viability. The influence of these treatments on expression of biosynthetic genes was also investigated. MeJA induced up-regulation of CYP71AV1, while miconazole induced up-regulation of CPR and DBR2.